Elipovimab
Elipovimab is a monoclonal antibody designed for the treatment of Ebola virus disease. It is one of the three antibodies in the Ebola treatment drug Inmazeb.
History[edit | edit source]
Elipovimab, along with atoltivimab and maftivimab, was developed by Regeneron Pharmaceuticals as part of a triple-antibody cocktail for the treatment of Ebola virus disease. The drug was approved for use in the United States in October 2020.
Mechanism of action[edit | edit source]
Elipovimab works by binding to the surface glycoprotein of the Ebola virus, preventing the virus from entering human cells. This stops the virus from replicating and spreading throughout the body.
Clinical trials[edit | edit source]
Elipovimab has been tested in several clinical trials, both as a standalone treatment and as part of the Inmazeb cocktail. These trials have shown that the drug is effective in treating Ebola virus disease, with a significant reduction in mortality compared to other treatments.
Side effects[edit | edit source]
Common side effects of elipovimab include fever, chills, fatigue, rash, and nausea. In rare cases, the drug can cause severe allergic reactions.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
